Earnings History Data for BioLineRx Ltd. (BLRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioLineRx Ltd.

Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-05-2022 PM 7:00 AM ET
(May 11)
BLRX BioLineRx Ltd. 55.31 -0.10 -0.15 -0.27 biolinerx GAAP EPS of -$0.02
[5/11/2022 7:09 AM]
1.06 -0.15 
(-12.40%)
1.18 -0.03 
(-2.48%)
1.05 - 3.62 381,672 260,000 6,237
16-03-2022 PM 7:00 AM ET
(Mar 16)
BLRX BioLineRx Ltd. 71.52 -0.08 -0.14 -0.61 biolinerx GAAP EPS of -$0.04 beats by $0.42
[3/16/2022 7:07 AM]
1.48 -0.04 
(-2.96%)
1.55 0.02 
(1.31%)
1.34 - 6.34 252,831 298,516 1,756
18-11-2021 PM 7:00 AM ET
(Nov 18)
BLRX BioLineRx Ltd. 135.24 -0.23 -0.13 -0.30 biolinerx EPS beats by $0.11
[11/18/2021 7:06 AM]
2.66 -0.11 
(-3.93%)
2.83 0.06 
(2.17%)
2.17 - 6.34 418,701 260,000 20,764
18-08-2021 PM 7:00 AM ET
(Aug 18)
BLRX BioLineRx Ltd. 142.77 -0.15 -0.12 -0.45 biolinerx EPS beats by $0.11
[8/18/2021 7:07 AM]
2.76 -0.13 
(-4.53%)
2.86 -0.03 
(-1.04%)
1.40 - 6.34 1,380,095 490,000 80,783
26-05-2021 PM 7:00 AM ET
(May 26)
BLRX BioLineRx Ltd. 137.91 -0.27 -0.15 -0.60 biolinerx EPS beats by $0.17
[5/26/2021 7:05 AM]
2.91 -0.04 
(-1.36%)
3.00 0.05 
(1.69%)
1.40 - 6.34 1,559,923 1,320,000 62,513
23-02-2021 PM 7:00 AM ET
(Feb 23)
BLRX BioLineRx Ltd. 141.39 -0.61 -0.25 -0.97 biolinerx EPS beats by $1.06
[2/23/2021 7:04 AM]
3.31 -0.13 
(-3.78%)
3.46 0.02 
(0.58%)
1.06 - 4.23 1,971,396 2,294,448 143,924
23-11-2020 PM 7:00 AM ET
(Nov 23)
BLRX BioLineRx Ltd. 49.04 -0.30 -0.36 -0.40 biolinerx EPS beats by $0.32
[11/23/2020 7:23 AM]
2.29 -0.35 
(-13.26%)
2.43 -0.21 
(-7.96%)
1.06 - 3.30 2,169,045 1,149,808 218,935
06-08-2020 PM 7:00 AM ET
(Aug 6)
BLRX BioLineRx Ltd. 44.27 -0.45 -0.60 -0.04 biolinerx EPS beats by $0.57
[8/6/2020 7:07 AM]
1.98 -0.36 
(-15.50%)
2.19 -0.16 
(-6.77%)
1.06 - 4.08 951,949 577,291 45,532
20-05-2020 PM 7:00 AM ET
(May 20)
BLRX BioLineRx Ltd. 23.98 -0.60 -0.83 -0.75 biolinerx EPS beats by $0.78
[5/20/2020 7:05 AM]
1.92 -0.22 
(-10.28%)
2.12 -0.02 
(-0.93%)
1.06 - 6.45 156,200 51,893 8,350